Results 251 to 260 of about 712,221 (400)

Incidental Detection of Thyroid Neoplasm on 99mTc-SestaMIBI Myocardial Perfusion Scan - A Novel Tumour Tracer Revisted [PDF]

, 2015
Manjit Sarma, Padma Subramanyam, Shanmuga Sundaram Palaniswamy   +2 more
openalex   +1 more source

Thyroid, thyroid neoplasms and metformin

Clinical and experimental thyroidology, 2011
openaire   +3 more sources

Noninvasive follicular thyroid neoplasm with papillary‐like nuclear features (NIFTP): Implications for the risk of malignancy (ROM) in the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC)

Cancer Cytopathology, 2018
Haijun Zhou, Z. Baloch, R. Nayar, T. Bizzarro, G. Fadda, Deepti Adhikari-Guragain, J. Hatem, L. Larocca, Julia Samolczyk, J. Slade, E. Rossi   +10 more
semanticscholar   +1 more source

Porous polyethylene in reconstructive head and neck surgery [PDF]

, 1985
Berghaus, Alexander
core   +1 more source

FNAC diagnosis of medullary carcinoma thyroid: A report of three cases with review of literature

Journal of Cytology, 2010
Medullary carcinoma of the thyroid is an unusual neoplasm, which is associated with specific supportive diagnostic markers. Despite this, its cytological diagnosis is often difficult. We report herewith three cases of medullary thyroid carcinoma.
Mehdi Ghazala, Maheshwari Veena, Ansari Hena, Sadaf Lubna, Khan Mohammad   +4 more
doaj  

Impact of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on fine-needle aspiration diagnoses of thyroid nodules. [PDF]

Proc (Bayl Univ Med Cent), 2021
Chen L, Liu L, Hodjat P, Leng B.
europepmc   +1 more source

Non-invasive follicular thyroid neoplasm with papillary-like nuclei: reducing overtreatment by reclassifying an indolent variant of papillary thyroid cancer [PDF]

, 2016
David Poller, Yuri E. Nikiforov
openalex   +1 more source

Bioactives From Brown Algae: Antioxidant, Anti‐Inflammatory, Anticancer, and Antimicrobial Potential

ChemBioEng Reviews, EarlyView.
This review explores key bioactives in brown algae and their antioxidant, anti‐inflammatory, anticancer, and antimicrobial properties. Covering studies from 2014 to 2024, it highlights their relevance in pharmaceuticals, nutraceuticals, cosmetics, and foods, while addressing challenges and future directions to unlock their full potential.
Irvin Fonseca‐Barahona, Kaveh Shahbaz, Saeid Baroutian   +2 more
wiley   +1 more source

Evaluation of the Pharmacokinetic Drug Interaction of Capmatinib With Itraconazole and Rifampicin and Potential Impact on Renal Transporters in Healthy Subjects

The Journal of Clinical Pharmacology, Volume 63, Issue 2, Page 228-238, February 2023., 2023
Abstract Capmatinib is a highly specific, potent, and selective mesenchymal–epithelial transition factor inhibitor predominantly eliminated by cytochrome P450 (CYP) 3A4 and aldehyde oxidase. Here, we investigated the effects of a strong CYP3A inhibitor (itraconazole) and a strong CYP3A inducer (rifampicin) on single‐dose pharmacokinetics of capmatinib.
Xiaoming Cui, Xinhui Chen, Nathalie Pognan, Tirtha Sengupta, Gholamreza Rahmanzadeh, Ruediger Kornberger, Monica Giovannini   +6 more
wiley   +1 more source

Thyroid neoplasm in Makkah region, Saudi Arabia. A retrospective epidemiological study. [PDF]

Saudi Med J, 2020
Alkaff HH, Besharah BO, Bukhari DH, Sayed SI, Alessa MA, Abdelmonim SK, Alghamdi SA, Alghamdi FE, Abu Suliman OA, Abi Sheffah FR, Al-Tammas AH, Al-Zahrani RA, Marglani OA, Heaphy JC, Bawazir OA, Alherabi AZ.   +15 more
europepmc   +1 more source